Volltextsuche
Hinweis: Bitte geben Sie einen Suchbegriff ein, z.B. "BMW", um alle Analysen und News über BMW aufgelistet zu bekommen, die innerhalb der Site von AktienCheck vorhanden sind! Zusätzlich können Sie noch eine Zeitspanne auswählen.
Suchergebnisse: (33819 Ergebnisse gefunden) Es w.
| Datum | Thema | |
|---|---|---|
| 17.04.26 | Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| WALTHAM, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune. [...] | ||
| 17.04.26 | CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| CAMBRIDGE, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of rest. [...] | ||
| 17.04.26 | 4DMT Announces New Employment Inducement Grants | |
| EMERYVILLE, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on April 14, 2026, the compensation committee of the Company’s board of directors granted five new non-executive employees 67,600 Restricted Stock Units (RSUs). [...] | ||
| 17.04.26 | ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules | |
| SOUTH SAN FRANCISCO, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, announced that the Compensation Committee of the Board of Directors of ALX Oncology approved the granting of an inducement stock option to purchase a total of 800,000 shares of ALX Oncology’s common stock to Jeff Knight, M.P.H. [...] | ||
| 17.04.26 | VALUE LINE, INC. DIVIDEND HAS JUST BEEN RAISED FROM $1.30 TO $1.40 (ANNUALIZED) – ITS 12TH CONSECUTIVE INCREASE | |
| NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc. (NASDAQ – VALU) announced today that its Board of Directors has just raised its quarterly dividend, which will be $0.35 per common share ($1.40 annualized). The new higher cash dividend is payable on May 12, 2026 to stockholders of record on April 27, 2026. [...] | ||
| 17.04.26 | Commerzbank's Capital Strategy Takes Center Stage as Takeover Bid Stalls | |
| Commerzbank is moving forward with a clear message of independence, underscored by a fresh capital market transaction and a shareholder-friendly capital return policy. This comes as the German lender publicly rebuffs a takeover proposal from Italy's UniCredit, setting the stage for a pivotal few months. [...] | ||
| 17.04.26 | PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma | |
| Houston, Texas and Tuebingen, Germany, April 17, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today announced that an abstract highlighting a pediatric patient treated with a PRAME-directed cell therapy using Immatics’ PRAME T-cell receptor (TCR) has been accepted for a late-breaking poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026 in San Diego, California, USA. [...] | ||
| 17.04.26 | RWE's Shareholder Returns and Strategic Execution Drive Decade-High Valuation | |
| Shares in German energy giant RWE AG have surged to their highest level in ten years, propelled by a potent combination of consistent shareholder returns and strategic positioning that is winning analyst favor. The stock reached €59.14 on April 15, capping a year-to-date gain exceeding 30 percent for 2026. [...] | ||
| 17.04.26 | Chino Commercial Bancorp Reports 24.7% Increase in Net Earnings | |
| CHINO, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Chino Commercial Bancorp (OTC: CCBC), the parent company of Chino Commercial Bank, N.A., announced the results of operations for the Bank and the consolidated holding company for the first quarter ended March 31, 2026.. [...] | ||
| 17.04.26 | OMV's Fuel Rebate Standoff and IPO Delay Cloud Upcoming Earnings | |
| Investors in Austrian energy group OMV are navigating a dual storm of regulatory conflict and strategic recalibration as the company approaches its first-quarter earnings report. While the stock has defied political uproar to climb nearly 24% year-to-date, reaching €58.55, underlying operational and financial pressures are mounting. [...] |
